Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024

SELL
$145.6 - $158.88 $2,184 - $2,383
-15 Reduced 0.76%
1,968 $308,000
Q3 2023

Nov 08, 2023

BUY
$155.75 - $174.48 $119,148 - $133,477
765 Added 62.81%
1,983 $308,000
Q2 2023

Aug 09, 2023

SELL
$154.35 - $166.11 $141,230 - $151,990
-915 Reduced 42.9%
1,218 $201,000
Q1 2023

May 10, 2023

BUY
$151.05 - $180.26 $30,814 - $36,773
204 Added 10.58%
2,133 $330,000
Q4 2022

Feb 09, 2023

SELL
$160.2 - $179.79 $70,968 - $79,646
-443 Reduced 18.68%
1,929 $340,000
Q3 2022

Oct 31, 2022

BUY
$161.33 - $179.52 $79,213 - $88,144
491 Added 26.1%
2,372 $393,000
Q2 2022

Aug 05, 2022

SELL
$168.19 - $186.01 $12 Million - $13.2 Million
-71,224 Reduced 97.43%
1,881 $333,000
Q1 2022

May 13, 2022

BUY
$158.14 - $179.59 $11.2 Million - $12.8 Million
71,121 Added 3584.73%
73,105 $12 Million
Q4 2021

Apr 08, 2022

SELL
$155.93 - $173.01 $16.9 Million - $18.8 Million
-108,392 Reduced 98.2%
1,984 $339,000
Q4 2021

Feb 14, 2022

BUY
$155.93 - $173.01 $6.13 Million - $6.8 Million
39,331 Added 55.36%
110,376 $339,000
Q3 2021

Oct 20, 2021

SELL
$161.5 - $179.47 $61,854 - $68,737
-383 Reduced 0.54%
71,045 $11.5 Million
Q2 2021

Aug 12, 2021

SELL
$159.48 - $171.07 $288,818 - $309,807
-1,811 Reduced 2.47%
71,428 $11.8 Million
Q1 2021

May 06, 2021

BUY
$153.07 - $170.48 $73,932 - $82,341
483 Added 0.66%
73,239 $12 Million
Q4 2020

Feb 01, 2021

SELL
$137.11 - $157.38 $43,875 - $50,361
-320 Reduced 0.44%
72,756 $11.5 Million
Q3 2020

Nov 03, 2020

BUY
$140.38 - $153.83 $219,133 - $240,128
1,561 Added 2.18%
73,076 $10.9 Million
Q2 2020

Aug 10, 2020

BUY
$128.81 - $155.51 $110,261 - $133,116
856 Added 1.21%
71,515 $10.1 Million
Q1 2020

Apr 28, 2020

SELL
$111.14 - $153.99 $321,194 - $445,031
-2,890 Reduced 3.93%
70,659 $9.27 Million
Q4 2019

Feb 04, 2020

SELL
$127.5 - $146.44 $599,505 - $688,560
-4,702 Reduced 6.01%
73,549 $10.7 Million
Q3 2019

Oct 16, 2019

SELL
$126.95 - $142.14 $326,769 - $365,868
-2,574 Reduced 3.18%
78,251 $10.1 Million
Q2 2019

Jul 25, 2019

SELL
$131.15 - $144.24 $69,902 - $76,879
-533 Reduced 0.66%
80,825 $11.3 Million
Q1 2019

Apr 18, 2019

SELL
$125.72 - $139.79 $39,476 - $43,894
-314 Reduced 0.38%
81,358 $11.4 Million
Q4 2018

Jan 29, 2019

SELL
$122.84 - $147.84 $37,220 - $44,795
-303 Reduced 0.37%
81,672 $10.5 Million
Q3 2018

Nov 01, 2018

SELL
$121.58 - $142.88 $182,126 - $214,034
-1,498 Reduced 1.79%
81,975 $11.3 Million
Q2 2018

Jul 30, 2018

BUY
$119.4 - $131.76 $153,309 - $169,179
1,284 Added 1.56%
83,473 $10.1 Million
Q1 2018

Apr 16, 2018

BUY
$125.1 - $148.14 $183,396 - $217,173
1,466 Added 1.82%
82,189 $10.5 Million
Q4 2017

Jan 16, 2018

BUY
$131.22 - $143.62 $69,021 - $75,544
526 Added 0.66%
80,723 $11.3 Million
Q3 2017

Oct 18, 2017

BUY
$129.47 - $135.38 $10.4 Million - $10.9 Million
80,197
80,197 $10.4 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $410B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Baltimore Washington Financial Advisors, Inc. Portfolio

Follow Baltimore Washington Financial Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baltimore Washington Financial Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Baltimore Washington Financial Advisors, Inc. with notifications on news.